BackCerevel Therapeutics Holdings Overview
Cerevel Therapeutics Holdings Inc

Cerevel Therapeutics Holdings Target Price

Analysts' 12-month price predictions for CERE.

Get informed when a big investor buys or sells

+ Follow

Share Price

$44.96

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2022-12-06J.P. Morgan$4011% downsideOpen
2022-08-15Mizuho SecuritiesGraig Suvannavejh$2739.9% downsideOpen